ΒΡΟΓΧΙΚΟ ΑΣΘΜΑ ΚΑΙ ΔΙΑΤΡΟΦΗ
Παραπομπές
1. Bergmann KC. Asthma bronchiale - viele Formen, viele Therapien [Bronchial asthma - many types, different therapies]. Dtsch Med Wochenschr. 2016 May;141(10):687-92. German. doi: 10.1055/s-0042-104795. Epub 2016 May 13. PMID: 27176061.
https://pubmed.ncbi.nlm.nih.gov/27176061/
2. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012 Mar;12:204. DOI: 10.1186/1471-2458-12-204. PMID: 22429515; PMCID: PMC3353191.
http://europepmc.org/article/MED/22429515
3. Behera D, Sehgal IS. Bronchial asthma--Issues for the developing world. The Indian Journal of Medical Research. 2015 Apr;141(4):380-382. DOI: 10.4103/0971-5916.159237. PMID: 26112836; PMCID: PMC4510715.
https://europepmc.org/article/MED/26112836
4. Calabrese C, Carpagnano GE, Patella V, Vatrella A, Santus P. Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma? Minerva Med 2015 October;106(5 Suppl 1):9-11.
https://www.minervamedica.it/en/journals/minerva-medica/article.php?cod=R10Y2015S03A0009#modal_3
5. - - -
1. Bergmann KC. Asthma bronchiale - viele Formen, viele Therapien [Bronchial asthma - many types, different therapies]. Dtsch Med Wochenschr. 2016 May;141(10):687-92. German. doi: 10.1055/s-0042-104795. Epub 2016 May 13. PMID: 27176061.
https://pubmed.ncbi.nlm.nih.gov/27176061/
2. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012 Mar;12:204. DOI: 10.1186/1471-2458-12-204. PMID: 22429515; PMCID: PMC3353191.
http://europepmc.org/article/MED/22429515
3. Behera D, Sehgal IS. Bronchial asthma--Issues for the developing world. The Indian Journal of Medical Research. 2015 Apr;141(4):380-382. DOI: 10.4103/0971-5916.159237. PMID: 26112836; PMCID: PMC4510715.
https://europepmc.org/article/MED/26112836
4. Calabrese C, Carpagnano GE, Patella V, Vatrella A, Santus P. Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma? Minerva Med 2015 October;106(5 Suppl 1):9-11.
https://www.minervamedica.it/en/journals/minerva-medica/article.php?cod=R10Y2015S03A0009#modal_3
5. - - -
